Skip to main content

Table 1 Baseline patient characteristics (n = 36)

From: Capecitabine and oxaliplatin combined with bevacizumab are feasible for treating selected Japanese patients at least 75 years of age with metastatic colorectal cancer

Clinical characteristic

Number of patients (%)

Sex

 Male

21 (58.3)

 Female

15 (41.7)

Age (years)

 

 Median (range)

78 (75–86)

ECOG performance status

 0

30 (83.3)

 1

6 (16.7)

Primary sites

 Colon

24 (66.7)

 Rectum

12 (33.3)

Primary tumor resection

 Performed

23 (63.9)

 Not performed

13 (36.1)

Adjuvant chemotherapy

 

 Performed

9 (25.0)

 Not performed

27 (75.0)

Appearance of metastasis

 Synchronous

19 (52.7)

 Metachronous

17 (47.3)

Metastatic sites

 Liver

21 (58.3)

 Lung

13 (36.1)

 Lymph nodes

14 (38.9)

 Peritoneum

2 (5.6)

 Other

2 (5.6)

Number of metastatic sites

 1

23 (63.9)

 2

11 (30.5)

 3

2 (5.6)

Creatinine clearance (mL/min)

 Median (range)

60.8 (32.6–84.6)

  1. ECOG Eastern Cooperative Oncology Group